Skip to main content

Year: 2021

Tecnoglass Provides Business Update and Increases Full Year 2021 Growth Outlook

– Revenues of $456 Million and Adjusted EBITDA of $140 Million Year to Date Through November 2021 – – Operating Cashflow of Approximately $100 Million Through November 2021 – – Increases Full Year 2021 Outlook for Revenue and Adjusted EBITDA to a Range of $490–495 Million and $147-150 Million Respectively – – Provides Comments on What It Believes Are Inaccurate and Groundless Statements Made in Short Seller Report – BARRANQUILLA, Colombia, Dec. 09, 2021 (GLOBE NEWSWIRE) — Tecnoglass, Inc. (NASDAQ: TGLS) (“Tecnoglass” or the “Company”), a leading manufacturer of architectural glass, windows, and associated aluminum products serving the global residential and commercial end markets, today updated the financial outlook it disclosed on November 8, 2021 for full year 2021. Year to date through...

Continue reading

WPFH Announces Acquisition of KPOP 1004 Retail Chain

LOS ANGELES, CA, Dec. 09, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — World Poker Fund Holdings, Inc. (OTC PINK: WPFH), announces today that it has signed a definitive agreement to acquire Kimco Industries Inc., the owner and operator of the retail chain KPOP 1004, a K-POP and K-Beauty specialty store. KPOP 1004 stores are currently located in the Ontario Mills Shopping Center of Ontario, CA; Westfield Valencia Town Center of Valencia, CA; and the Premium Outlets of Las Vegas, NV.  Over the next 24 months, Kimco intends to open up stores in four more markets including Houston, Seattle, Newark, and Miami. As part of the acquisition agreement, WPFH will be changing its name to KPOP 1004, complete audits, and file a Form 10 registration statement with the SEC in preparation for OTCQB and KOSDAQ (the Korean Stock Exchange) up-listing...

Continue reading

Verano to Open MÜV Orange Park Dispensary, the Company’s Third Jacksonville Area Location and 40th Florida Storefront Statewide

Orange Park is the 11th MÜV dispensary to open in 2021, growing Verano’s footprint to 40 Florida dispensaries and 92 locations nationwide1 MÜV Orange Park will provide high-quality medical cannabis therapeutics to a region that has experienced a population boom over the last decade; Clay County and neighboring Duval County saw population increases of 14% and 15%, respectively, from 2010 – 2020, according to U.S. Census Data MÜV Orange Park is located on busy Blanding Boulevard, a thoroughfare that sees average daily traffic of 76,000 cars, according to the Florida Department of TransportationCHICAGO, Dec. 09, 2021 (GLOBE NEWSWIRE) — Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or “the Company”), a leading multi-state cannabis company, today announced the opening of a new MÜV Florida dispensary, located...

Continue reading

FLOW CAPITAL PORTFOLIO COMPANY MINILUXE COMPLETES TSX VENTURE LISTING

TORONTO, Dec. 09, 2021 (GLOBE NEWSWIRE) — Flow Capital Corp., (“Flow”) (TSXV:FW) is proud to announce that portfolio company MiniLuxe, Inc., (“MiniLuxe”) (TSXV: MNLX) started trading on the TSX Venture exchange, yesterday. “MiniLuxe is revolutionizing the self-care industry, providing a more socially responsible and digitally-driven approach to nail care services,” said Alex Baluta, Chief Executive Officer of Flow Capital. “We were excited to partner with MiniLuxe when we closed our investment in April of this year. The visibility and additional capital raised will only help MiniLuxe accelerate its growth and expansion. This is a perfect example of Flow aims to help companies extend their growth runway with minimally dilutive, founder friendly, capital.” About MiniLuxe MiniLuxe, a Delaware corporation based in Boston,...

Continue reading

Context Therapeutics® Announces Positive Data from ONA-XR in Early Breast Cancer at 2021 San Antonio Breast Cancer Symposium

Data demonstrated ONA-XR decreased proliferation in tumors with high PR+ at baseline in early breast cancer Two additional metastatic breast cancer clinical trials in progress also presented PHILADELPHIA, Dec. 09, 2021 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, today announced that data from the window-of-opportunity clinical trial of onapristone extended release (ONA-XR) in postmenopausal patients with progesterone receptor positive (PR+) early breast cancer demonstrated ONA-XR significantly increased suppression of tumor cell proliferation. The data were presented today during the 2021 San Antonio Breast Cancer Symposium (SABCS). The Phase 0 open-label, single-arm, multicenter ONAWA (SOLTI-1802)...

Continue reading

Spotlight Poster Presentation at San Antonio Breast Cancer Symposium SABCS 2021 Shows Oncocyte’s DetermaIO™ Clinical Test Predicts Response to Immunotherapy in Triple Negative Breast Cancer

Data supports the use of DetermaIO as a pan-cancer diagnostic tool, now addressing an unmet need for patients with triple negative breast cancer, the most aggressive type of breast cancer DetermaIO shown to work across multiple platforms, including PCR and NGS, with the potential to be used for pan-cancer diagnostic testing worldwide Oncocyte supported a Continuing Medical Education event on Immunotherapy Biomarkers at SABCS, hosting key opinion leaders from the United States and Europe IRVINE, Calif., Dec. 09, 2021 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing clear insights that inform critical decisions in the diagnosis, treatment, and monitoring of cancer, today announced results showing the ability of the Company’s DetermaIO™...

Continue reading

SuRo Capital Corp. Prices Public Offering of $70,000,000 6.00% Notes Due 2026

SAN FRANCISCO, Dec. 09, 2021 (GLOBE NEWSWIRE) — SuRo Capital Corp. (“SuRo Capital” or the “Company”) (Nasdaq:SSSS) today announced that it has priced a registered public offering of $70,000,000 aggregate principal amount of its 6.00% Notes due 2026 (the “Notes”), which will result in net proceeds to the Company of approximately $67,462,500 (or approximately $77,634,375 if the underwriters fully exercise the overallotment option described below) based on a public offering price of 100% of the aggregate principal amount of the Notes, after deducting payment of underwriting discounts and commissions and estimated offering expenses payable by the Company. The Notes will mature on December 30, 2026 and may be redeemed in whole or in part at any time, or from time to time, at the Company’s option on or after December 30, 2024. The Notes...

Continue reading

FirstCash Announces Upsize and Pricing of $550 Million Senior Notes Due 2030 to Fund Part of its Acquisition of American First Finance

FORT WORTH, Texas, Dec. 09, 2021 (GLOBE NEWSWIRE) — FirstCash, Inc. (the “Company”) (Nasdaq: FCFS) today announced that it has upsized and priced its previously announced private offering (the “Offering”) of $550 million in aggregate principal amount of senior notes due 2030 (the “Notes”), representing an increase of $25 million in aggregate principal amount from the previously announced proposed offering size. The Notes will pay interest semi-annually at a rate of 5.625% per annum payable on January 1 and July 1 of each year beginning on July 1, 2022. The Notes will be unsecured senior obligations of the Company. The Offering is expected to close on December 13, 2021, subject to the satisfaction of customary closing conditions. The Company intends to use the proceeds from the Offering to finance the cash consideration of the previously...

Continue reading

Inscape Announces Second Quarter 2022 Financial Results

HOLLAND LANDING, Ontario, Dec. 09, 2021 (GLOBE NEWSWIRE) — Inscape (TSX: INQ), a leading designer and manufacturer of furnishings and movable wall systems for the workplace, today announced its results of operations for the three and six months ended October 31, 2021.   “Second quarter fiscal 2022 results are beginning to evidence our improving sales pipeline and the improving economy. Our Walls operation recorded its highest sales revenue to date this fiscal year and an improving financial profile reflecting the efforts by management to lower its cost base and re-align its footprint during the calendar year. Sales for the Company for the quarter were up 35% year over year, driven by the improving outlook for our Walls operation, up 127.9%, and a solid improvement in our Furniture sales levels, up 9.4%, versus the depths of the...

Continue reading

Encore Capital Group Announces Final Results of Tender Offer

SAN DIEGO, Dec. 09, 2021 (GLOBE NEWSWIRE) — Encore Capital Group, Inc. (NASDAQ: ECPG) (“Encore”) announced today the final results of its modified “Dutch auction” tender offer to purchase with cash up to $300 million of shares (the “shares”) of its common stock (the “common stock”) which expired one minute after 11:59 P.M. (New York City time) on December 2, 2021. Based on the final count by the depositary for the tender offer, a total of 4,471,995 shares of common stock were validly tendered and not validly withdrawn at or below the price of $60.00 per share. Encore accepted all of these shares of common stock for purchase at the purchase price of $60.00 per share, for a total cost of $268,319,700, excluding fees and expenses. “We are pleased by the outcome of this tender offer which achieved our objective of efficiently accelerating...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.